Therapy of Antibody-mediated Autoimmune Diseases by Bortezomib (TAVAB)
Clinical trial NCT02102594 · TERMINATED
Trial details
- NCT number
- NCT02102594
- Sponsor
- Charite University, Berlin, Germany
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2019-08-30
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.